Edit
Sumitomo Dainippon Pharma Oncology
http://www.bostonbiomedical.com/Last activity: 04.03.2024
Active
Sumitomo Dainippon Pharma Oncology is a global developer of novel cancer therapeutics. Learn about our diverse and purposeful pipeline of targeted therapies.
Location: United States, Massachusetts, Norwood
Employees: 51-200
Founded date: 2006
Investors 1
| Date | Name | Website |
| - | Mitsui Glo... | mitsui-glo... |
Mentions in press and media 4
| Date | Title | Description |
| 04.03.2024 | Beta Catenin Market Key Players, Demand and Growth Trends by 2024-2031 | Boston Biomedical Inc, Marina Biotech Inc | Beta Catenin Market growth BURLINGAME, CALIFORNIA, UNITED STATES, March 4, 2024 /EINPresswire.com/ -- Beta Catenin Market Research focuses on the key trends prevailing in the Global Beta Catenin Industry sector. The existing Industry scenar... |
| 03.12.2019 | AbbVie picks first Alzheimer's, Parkinson's targets in Mission pact; Amarin files for Vascepa OK in Europe | → Back in 2018, AbbVie teamed up with protein degradation experts at Mission Therapeutics to focus on deubiquitylating enzymes, or DUBs, to tackle Alzheimer’s and Parkinson’s disease. And today, the pact has reached its... |
| 20.07.2016 | DNA pioneer James Watson: The cancer moonshot is ‘crap’ but there is still hope | James Watson, whose 1953 discovery of the structure of DNA with Francis Crick launched the revolution in molecular biology, says recent heart surgery has wreaked havoc on his long-term memory (though not his tennis serve: the 88-year-old ca... |
| 28.12.2012 | The 10 biggest VC-backed acquisitions of 2012 | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today! While 2012 saw some spectacularly large IPOs like... |